Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP4 | P15090 | 3/20 | 0.43 |
| ▸ | FABP3 | P05413 | 2/20 | 0.43 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | PLG | P00747 | 4/20 | 0.35 |
| ▸ | PLAU | P00749 | 4/20 | 0.35 |
| ▸ | F10 | P00742 | 2/20 | 0.35 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.35 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.34 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5179693 | 0.83 | ALDH1A1 (0.39) | ALDH1A1 | |
| SCHEMBL23052181 | 0.81 | EPHX2 (0.51) | FABP4FABP3FABP5EPHX2GAA | |
| SCHEMBL6371598 | 0.76 | EPHX2 (0.42) | FABP4FABP3FABP5EPHX2GAA | |
| SCHEMBL2670888 | 0.76 | EPHX2 (0.42) | FABP4FABP3FABP5EPHX2GAA | |
| SCHEMBL810153 | 0.74 | CA1 (0.45) | EPHX2ALDH1A1NR3C1 | |
| SCHEMBL21924130 | 0.73 | FABP4 (0.46) | FABP4FABP3FABP5EPHX2GAA | |
| SCHEMBL810645 | 0.73 | ALDH1A1 (0.35) | ALDH1A1 | |
| P-Cymene SCHEMBL5423465 | 0.73 | ALDH1A1 (0.51) | GAATDP1ALDH1A1 | |
| P-Cymene SCHEMBL5426999 | 0.73 | ALDH1A1 (0.51) | GAATDP1ALDH1A1 | |
| SCHEMBL21924129 | 0.72 | EPHX2 (0.46) | FABP4FABP3FABP5EPHX2GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2399895-B1 | Process for producing optically active aliphatic fluoroalcohol | KANTO KAGAKU (JP) | 2018-08-08 | — | — | EP | disclosed |
| US-9162934-B2 | Process for producing optically active alcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2015-10-20 | — | — | US | disclosed |
| EP-2394977-B1 | Process for producing optically active alcohol | KANTO KAGAKU (JP) | 2014-01-08 | — | — | EP | disclosed |
| US-8558033-B2 | Process for producing optically active aliphatic fluoroalcohol | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2013-10-15 | — | — | US | disclosed |
| US-20110319671-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2011-12-29 | — | — | US | disclosed |
| EP-2399895-A2 | Process for producing optically active aliphatic fluoroalcohol | Kanto Kagaku Kabushiki Kaisha (JP) | 2011-12-28 | — | — | EP | disclosed |
| EP-2394977-A1 | Process for producing optically active alcohol | Kanto Kagaku Kabushiki Kaisha (JP) | 2011-12-14 | — | — | EP | disclosed |
| US-20110282077-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2011-11-17 | — | — | US | disclosed |
| US-7268250-B2 | Process for producing optically active compound | KANTO KAGAKU KABUSHIKI KAISHA (JP) | 2007-09-11 | — | — | US | disclosed |
| EP-1439159-B1 | Process for producing optically active compound | KANTO KAGAKU (JP) | 2007-06-20 | — | — | EP | disclosed |
| US-20040176616-A1 | Process for producing optically active compound | KANTO KAGAKU KABUSHIKI KAISHA | 2004-09-09 | — | — | US | disclosed |
| EP-1439159-A1 | Process for producing optically active compound | Kanto Kagaku Kabushiki Kaisha (JP) | 2004-07-21 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040176616-A1 | Process for producing optically active compound | OSTC, NPEPPS, PPOX | FABP4 4646/4885FABP3 4846/4885FABP5 4658/4885 |
| US-20110282077-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1A, ADH1C, ADH5 | FABP4 2907/4885FABP3 4379/4885FABP5 3575/4885 |
| US-20110319671-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALIPHATIC FLUOROALCOHOL | ADH1A, ADH1C, ADH5 | FABP4 924/4885FABP3 2573/4885FABP5 896/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.